Dr. Scott Gottlieb
Former Editor, Forbes/Gottlieb Biotech Investor

Scott Gottlieb, M.D. is a former senior policy adviser to the Commissioner of the Food and Drug Administration (FDA) and to the Administrator of the Centers for Medicare and Medicaid Services (CMS) at the Department of Health and Human Services. At AEI, Dr. Gottlieb researched FDA and CMS regulatory policies, the development of new medical technology, and political and clinical trends in medicine. Dr. Gottlieb is also the author of the new Forbes/Gottlieb Medical Technology Investor, an investment newsletter. 

Professional Experience
-Editor, http://www.fdainsider.com/ , 2005-present
-Author, Forbes/Gottlieb Medical Technology Report (investment newsletter), 2004-present
-Staff writer, British Medical Journal , 1997-present
-Senior adviser to the Administrator, Center for Medicare and Medicaid Services, Department of Health and Human Services, 2004
-Director of Medical Policy Development, Food and Drug Administration (FDA), 2004
-Senior adviser for Medical Technology to the FDA commissioner, 2003-2004
-Medical internist, Stamford Hospital, 2003-2004
-Author, Gilder Biotech Report , 2000-2002
-Senior editor, "Pulse," Journal of the American Medical Association (JAMA), 1996-2001
-Health care analyst, Alex Brown & Sons (investment bank), 1994-1995


Education
M.D., Mount Sinai School of Medicine
B.A., economics, Wesleyan University